MARKET

TLSIW

TLSIW

TriSalus Life Sciences Inc.
NASDAQ
1.500
0.000
0.00%
Closed 09:30 02/09 EST
OPEN
1.580
PREV CLOSE
1.500
HIGH
1.580
LOW
1.580
VOLUME
318
TURNOVER
--
52 WEEK HIGH
5.000
52 WEEK LOW
0.4201
MARKET CAP
--
P/E (TTM)
-0.7440
1D
5D
1M
3M
1Y
5Y
1D
TriSalus Life Sciences Appoints Michael Stansky to Board
Reuters · 17h ago
TRISALUS LIFE SCIENCES APPOINTS VETERAN HEALTHCARE INVESTOR MICHAEL STANSKY TO ITS BOARD OF DIRECTORS
Reuters · 17h ago
Weekly Report: what happened at TLSIW last week (0202-0206)?
Weekly Report · 21h ago
Weekly Report: what happened at TLSIW last week (0126-0130)?
Weekly Report · 02/02 09:32
Weekly Report: what happened at TLSIW last week (0119-0123)?
Weekly Report · 01/26 09:32
Weekly Report: what happened at TLSIW last week (0112-0116)?
Weekly Report · 01/19 09:35
TriSalus Life Sciences Projects 2026 Revenue of $60 Million to $62 Million
Reuters · 01/12 12:01
TRISALUS LIFE SCIENCES ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL-YEAR 2025 RESULTS AND 2026 REVENUE GUIDANCE
Reuters · 01/12 12:00
More
About TLSIW
TriSalus Life Sciences, Inc. is an oncology-focused medical technology company. The Company is seeking to transform outcomes for patients with solid tumors by integrating its delivery technology with standard-of-care therapies, and with its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 agonist, for a range of different therapeutic and technology applications. The Company’s platform includes devices that utilize a proprietary drug delivery technology and a clinical-stage investigational immunotherapy. The Company’s two Food and Drug Administration (FDA)-cleared devices use its proprietary Pressure-Enabled Drug Delivery (PEDD) approach to deliver a range of therapeutics: the TriNav Infusion System for hepatic arterial infusion of liver tumors and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. PEDD technology is a novel delivery approach designed to address the anatomic limitations of arterial infusion for the pancreas.

Webull offers TriSalus Life Sciences Inc stock information, including NASDAQ: TLSIW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLSIW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLSIW stock methods without spending real money on the virtual paper trading platform.